Skip to main content
. 2019 Dec 4;3(4):e356–e363. doi: 10.1055/s-0039-3401003

Table 2. Clinical characteristics of patients with intermediate-high risk PE ( n  = 97) who did or did not receive thrombolysis .

Received thrombolysis
N  = 17
Did not receive thrombolysis
N  = 80
p -Value
Clinical characteristics,
 Age, y (mean ± SD) 56.6 ± 20.3 73.3 ± 13.7 < 0.001
 Age > 80 y 0 (0) 28 (35) < 0.01
 Male gender 8 (47) 35 (44) 1.00
Risk factors for VTE,
 Cancer a 1 (5.9) 6 (7.5) 1.00
 Recent surgery b 1 (5.9) 6 (7.5) 1.00
 History of VTE 2 (12) 6 (7.5) 0.63
 Immobilization c 3 (18) 19 (24) 0.75
Comorbid diseases
 Chronic lung disease 0 (0) 10 (13) 0.20
 Chronic heart disease 0 (0) 5 (6.3) 0.58
Clinical symptoms and signs at presentation
 Syncope 4 (24) 25 (31) 0.77
 Chest pain 12 (71) 31 (39) 0.03
 Dyspnea 13 (76) 63 (79) 1.00
 Heart rate ≥ 110/min 13 (76) 29 (36) 0.02
 Arterial oxyhemoglobin saturation (SaO 2 ) < 90% 7 (41) 50 (63) 0.17
 SBP < 100 mm Hg 5 (29) 3 (3.8) < 0.01

Abbreviations: PE, pulmonary embolism; SBP, systolic blood pressure; SD, standard deviation; VTE, venous thromboembolism.

a

Active or under treatment in the last year.

b

In the previous month.

c

Immobilized patients defined as nonsurgical patients with limited mobility (i.e., total bed rest with bathroom privileges) for ≥ 4 days in the month prior to PE diagnosis.